Anti-IKK alpha antibody [EPR464]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(12 Publications)
Rabbit Recombinant Monoclonal IKK alpha antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 12 publications.
View Alternative Names
IKKA, TCF16, CHUK, Inhibitor of nuclear factor kappa-B kinase subunit alpha, I-kappa-B kinase alpha, IKK-A, IKK-alpha, IkBKA, IkappaB kinase, Conserved helix-loop-helix ubiquitous kinase, I-kappa-B kinase 1, Nuclear factor NF-kappa-B inhibitor kinase alpha, Transcription factor 16, IKK-1, IKK1, NFKBIKA, TCF-16
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IKK alpha antibody [EPR464] (AB109749)
ab109749 at 1/100 dilution staining IKK alpha in paraffin-embedded Human breast tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-IKK alpha antibody [EPR464] (AB109749)
All lanes:
Western blot - Anti-IKK alpha antibody [EPR464] (ab109749) at 1/1000 dilution
Lane 1:
Jurkat cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
HepG2 cell lysate at 10 µg
Lane 4:
Daudi cell lysate at 10 µg
Predicted band size: 84 kDa
false
- IP
Lab
Immunoprecipitation - Anti-IKK alpha antibody [EPR464] (AB109749)
IKK alpha was immunoprecipitated from 0.35 mg Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate 10 μg with 109749 at 1/50 dilution (2μg). VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate 10 μg
Lane 2 : ab109749 IP in Jurkat whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab109749 in Jurkat whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-IKK alpha antibody [EPR464] (ab109749)
Predicted band size: 84 kDa
Observed band size: 85 kDa
false
- WB
Unknown
Western blot - Anti-IKK alpha antibody [EPR464] (AB109749)
Lanes 1, 3 and 5 : Wild-type HAP1 cell lysate (20 μg)
Lanes 2, 4 and 6 : IKK alpha knockout HAP1 cell lysate (20 μg)
Lanes 1 and 2 : Green signal from target - ab109749 observed at 84 kDa
Lanes 3 and 4 : Red signal from loading control - ab8226 observed at 42 kDa
Lanes 5 and 6 : Merged (red and green) signal
ab109749 was shown to specifically react with IKK alpha when IKK alpha knockout samples were used. Wild-type and IKK alpha knockout samples were subjected to SDS-PAGE. ab109749 and ab8226 (loading control to beta actin) were both diluted at 1/1000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776)secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-IKK alpha antibody [EPR464] (ab109749)
Predicted band size: 84 kDa
false
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Breast cancer research : BCR 26:155 PubMed39506852
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:26 PubMed38199981
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Biochemical journal 479:305-325 PubMed35029639
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 134: PubMed34746949
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:924 PubMed34306193
2021
Applications
Unspecified application
Species
Unspecified reactive species
3 Biotech 11:258 PubMed33987074
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 40:1458-1475 PubMed33420370
2021
Applications
Unspecified application
Species
Unspecified reactive species
BioMed research international 2020:1481572 PubMed32908868
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 80:950-963 PubMed31900260
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Alzheimer's disease : JAD 60:1533-1545 PubMed29081415
2017
Applications
ICC/IF
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com